2016 American Transplant Congress Archives - Page 4 of 180

A 15-Year Retrospective Analysis of Acute Kidney Injury in Non Renal Solid Organ Transplant Recipients: Incidence, Outcome and Progression Toward End Stage Chronic Kidney Disease.

V. Cantaluppi,¹ A. Quercia,² S. Dellepiane,² D. Medica,² L. Biancone.²
A 30% Decrease in Post-kidney Transplant Estimated Glomerular Filtration Rate (eGFR) from 6 Mo-2 Y Is a Surrogate for 5 Y eGFR: Results from Clinical Trials in Organ Transplantation-(CTOT)-17.

G. Faddoul,¹ G. Nadkarni,¹ D. Hricik,² P. Heeger,¹ CTOT17 Investigators.
A 5-Year Multicenter Evaluation of Seasonal Influenza Infection in Transplant Recipients.

D. Kumar,¹ E. Cordero,⁴ E. Blumberg,² A. Limaye,⁵ M. Levi,⁷ L. Danziger-Isakov,⁹ J. Englund,⁸ S. Husain,¹ F. Silveira,¹⁰ G. Reid,⁶ T. Sharma,³ A. Humar.¹
A Call for a New Paradigm of Organ Allocation within the Confines of MELD for Those Who Are Not “the Sickest”.

T. Baker, A. Siarris, P. Accoh, D. Ladner.
A Change in Insulin Sensitivity and Lipid Profile in Renal Transplant Recipients Converted from Cyclosporine or Standard Release Tacrolimus to Once-Daily Prolonged Release Tacrolimus.

Y. Jung,¹ Y. Kim,¹ S. Kim,¹ H. Shin,¹ H. Rim,¹ H. Rhew.²
A Comparative Intention-to-Treat Analysis of Liver Transplantation for HCC – Living Donor Liver Transplant vs. Deceased Donor Liver Transplant.

K. Tomiyama, N. Goldaracena, A. Barbas, M. Dib, G. Levy, L. Lilly, A. Ghanekar, I. McGilvray, E. Renner, M. Bhat, M. Selzner, M. Cattral, N. Selzner, P. Greig, D. Grant, G. Sapisochin.
A Comprehensive Biomarker Study to Compare Tacrolimus and Mycophenolic Acid versus Half-Dose Tacrolimus and Everolimus in De Novo Kidney Transplant Patients in the Novartis US92 Study.

J. Klepacki,¹ J. Klawitter,¹ J. Klawitter,¹ A. Karimpour-fard,² E. Anderson,¹ G. Ingle,³ D. Patel,³ K. Johnson,⁴ D. Cibrik,⁴ U. Christians.¹
A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).

D. Kaul,¹ S. Tlusty,² A. Wilk,² C. Wolfe.¹
A Genome Wide Association Study of New Onset Diabetes After Transplant in Kidney Transplantation.

A. Giri,¹ M. Sanders,² D. Velez Edwards,¹ T. Ikizler,³ D. Roden,³ K. Birdwell.³
A Kidney Paired Donation Standard Acquisition Charge Pilot Program.

M. Rees,¹ L. Reece,² S. Rees,² B. Crandall,² A. Leichtman.⁴
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for the Detection of Subclinical Rejection Among Kidney Transplant Patients.

K. Jaglinski,¹ H. Uchida,¹ T. Inocencio,² K. Hughes.²
A Molecular Biopsy Test for Probability of Non-Adherence.

P. Halloran,^1,3 G. Einecke,² J. Reeve.¹
A Multi-Center Study of Factors That Increase Cognitive Load in Living Donor Liver Transplants.

A. Lee,¹ R. Khorzad,¹ E. Pomfret,² J. Guarrera,³ R. Fisher,⁴ M. Simpson,² A. Skaro,¹ A. Daud,¹ N. Salehitezangi,¹ D. Woods,¹ D. Ladner.¹
A Multi-Modular Approach for Training in Liver Procurement Accelerates Proficiency Gain.

I. Al Hasan,^1,2 H. Sharma,^1,2 M. Tun-Abraham,¹ D. Quan.^1,2
A Multidisciplinary Approach to Reviewing Patient Care in Abdominal Transplantation.

S. Lerner, M. Resta-Flarer, R. Shapiro, S. Florman, L. Kim-Schluger, V. Nair.
A Nationwide Analysis of Reoperation After kidney Transplant.

Z. Moghadamyeghaneh, M. Alameddine, G. Burke, G. Ciancio, L. Chen.
A New Diagnostic Score for Microvascular Inflammation in Antibody-Mediated Rejection in Heart Transplantation.

M. Racapé,¹ A. Loupy,² R. Guillemain,¹ A. François,³ P. Rouvier,⁴ C. Toquet,⁵ X. Jouven,¹ J. Venner,⁶ L. Hidalgo,⁶ J. Reeve,⁶ P. Bruneval,¹ J. Duong Van Huyen,² P. Halloran.²
A Non-Hematopoietic Erythropoietin Analogue, ARA 290, Prolonged Allogeneic Pancreatic Islet Graft Survival in a Mouse Model.

M. Watanabe,¹ M. Yao,¹ D. Andersson,¹ M. Brines,² T. Lundgren,¹ M. Kumagai-Braesch.¹
A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Response in the Sailor Randomized Multicenter Trial.

J. Ekberg,¹ B. Jespersen,² K. Skov,² M. Sarwal,³ T. Sigdel,³ S. Hsieh,³ P. Lindner.¹
A Novel Humanized Mouse Model Incorporating Non-Fetal Tissue.

M. Brown, I. Norman, Y. Zhou, W. Lou, J. Sullivan, W. Burlingham.
A Novel Inflammation-Targeting Tacrolimus Hydrogel for Liver Transplantation.

J. Jia,¹ J. Li,¹² Y. Zhou,¹ L. Jiang,¹ J. Zhang,¹ H. Lu,¹ H. Xie,¹ L. Zhou,¹ P. Kumur,³ S. Zheng.¹²
A Novel Intra-Abdominal Cooling System Prevents Graft Warming During Implantation for Robotic-Assisted Renal Transplantation.

R. Meier, M. Hagen, C. Joliat, J.-B. Buchs, A. Nastasi, R. Ruttimann, F. Lazeyras, P. Morel, L. Bühler.
A Novel Microfluidic Device for Purification of Pancreatic Islet Preparations.

W. Varhue,¹ L. Langman,² D. Bowers,³ S. Peirce-Cottler,³ N. Swami,¹ K. Brayman.²
A Novel Murine Orthotopic Forelimb Transplantation Model That Allows for Reliable Assessment of Post-Transplant Upper Extremity Function.

J. Budihardjo,¹ B. Kern,^1,2 S. Mermulla,¹ A. Quan,¹ C. Cadmi,¹ J. Lopez,¹ J. Park,¹ A. Hoke,¹ W. Lee,¹ S. Tuffaha,¹ G. Brandacher.¹
A Novel Quantitative CD45 Immunofluorescence Assay Can Measure Inflammatory Load in Renal Transplant Biopsies with Excellent Reproducibility and Repeatability.

Z. Laszik,¹ D. Dobi,¹ L. Laszik,¹ D. Ikle,² S. Chandran,¹ F. Vincenti.¹
A Novel Study to Determine the Association of Pre-Transplant Donor Specific Antibody and AT₁R Antibody with Kidney Transplant Outcomes Prior to Adoption of Solid Phase Antibody Assays.

R. Redfield, B. Astor, B. Jung-Hynes, D. Mandelbrot, D. Kaufman, A. Djamali, T. Ellis.
A Novel, Non-Viral mRNA Delivery System for Targeted Protein Translation in Human Islets.

J. Oberholzer,^1,2 D. Gutierrez,^1,2 E. Marchese,¹ M. Nourmohammadzadeh,^1,2 Y. Wang.^1,2
A P2X7R Mutation with Hypermetabolic T Cells, Th1/Th17 Skewing and Reduced Cardiac Allograft Survival.

F. D'Addio,^1,2 A. Vergani,³ L. Potena,⁴ A. Maestroni,² S. Tezza,¹ M. Ben Nasr,¹ V. Usuelli,² M. Sbolli,¹ L. Borgese,⁴ A. Iacovoni,⁵ D. Corradi,⁶ R. Abdi,⁷ A. Secchi,² R. Starling,⁸ M. Sayegh,^7,9 W. Harmon,¹ D. Briscoe,¹ P. Heeger,¹⁰ A. Chandraker,⁷ F. Grigioni,⁴ P. Fiorina.^1,2
A Pathway to Belatacept Monotherapy: Alemtuzumab, Belatacept and Rapamycin for Kidney Transplantation.

A. Guasch,¹ H. Xu,² A. Mehta,¹ A. Ghali,¹ S. Mead,¹ H. Gebel,¹ R. Bray,¹ C. Larsen,¹ T. Pearson,¹ A. Kirk.²
A Pilot Study of Donor: A Smart Phone Application for Identifying Live Kidney and Liver Donors.

K. Kumar,¹ E. King,¹ A. Muzaale,¹ J. Konel,¹ G. Segal,³ J. Arnold,³ K. Bramstedt,⁴ D. Segev,^1,2 A. Cameron.¹
A Prospective Carfilzomib-Based Desensitization Trial: Phase 1 Results.

S. Tremblay,¹ A. Shields,¹ R. Alloway,¹ P. Brailey,¹ B. Abu Jawdeh,¹ T. Latif,¹ J. Driscoll,¹ M. Pando,² A. Girnita,¹ E. Woodle.¹
A Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin (rATG) 3mg/Kg vs. 6mg/Kg in Kidney Transplant Patients Under Minimization Maintenance Immunosuppressive Regimen.

T. Sandes-Freitas, J. Junqueira Junior, M. Oliveira, C. Girão, R. Esmeraldo.
A Prospective Randomized, Comparative Trial of High-Dose Mizoribine versus Mycophenolate Mofetil in Combination with Tacrolimus and Basiliximab for Living Donor Renal Transplantation: A Multi-Center Trial.

H. Ishida,¹ K. Tanabe,¹ S. Takahara,² N. Amada,³ K. Takahashi,⁴ H. Toma.⁵
A Quantitative CD45 Assay May Improve Diagnostic Accuracy of the Diagnosis of Acute Cellular Rejection in Transplant Kidney Biopsies.

L. Laszik, S. Bowman, V. Walavalkar, F. Vincenti, Z. Laszik.
A Quantitative CD45 Immunohistochemical Assay Allows Precise and Reproducible Measurement of Inflammation in Renal Transplant Biopsies.

V. Walavalkar,¹ S. Bowman,¹ L. Laszik,¹ D. Ikle,² S. Chandran,¹ F. Vincenti,¹ Z. Laszik.¹
A Randomized-Controlled Trial Comparing the Efficacy of CYP3A5 Genotype-Based with Bodyweight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation.

N. Shuker,^1,2 R. Bouamar,² R. van Schaik,³ M. Clahsen -van Groningen,⁴ J. Damman,⁵ C. Baan,¹ J. van de Wetering,¹ A. Rowshani,¹ W. Weimar,¹ T. van Gelder,^1,2 D. Hesselink.¹
A Retrospective Analysis of Rabbit Antithymocyte Globulin Dosing, MELD, Race, and Weight on Infection and Rejection Rates in Liver Transplantation.

R. Imai, U. Wang.
A Retrospective Study of Simultaneous Bilateral Nephrectomies and Renal Transplantation in Recipients with Polycystic Kidney Disease.

E. Grodstein, D. Kaufman.
A Risk Quantification Score for Heart Transplants: A Heart Donor Risk Index.

A. Israni,^1,2 D. Zaun,¹ J. Snyder,¹ N. Salkowski,¹ H. Xiong,¹ B. Kasiske,^1,2 M. Colvin,^1,3 M. Colvin.^1,3
A Selective Biomarker in Blood Cells Identifies IFTA After Kidney Transplantation.

M. Matz,¹ C. Lorkowski,¹ K. Wu,³ H.-H. Neumayer,¹ M.-F. Mashreghi,² K. Budde.¹
A Single Histone/protein Acetyltransferase, Tip60, Is Absolutely Essential for Treg Survival and Function, and Its Inhibition Abrogates Induction of Treg-Dependent Allograft Tolerance.

L. Wang,¹ A. Beeler,² S. Dahiya,¹ R. Han,¹ W. Hancock.¹
A Successful Approach to Kidney Transplantation in Patients with Secondary Hyperoxaluria.

J. Roodnat,¹ A. Mik-van Egmond,² W. Visser,² S. Berger,³ W. van der Meijden,⁴ F. Knauf,⁵ M. Agteren van,¹ M. Betjes,¹ E. Hoorn.¹
A Sustained Viral Response Achieved with Sofosbuvir/Ledipasvir May Increase the Incidence of Acute Cellular Rejection Post Liver Transplantation.

K. Bortecen, R. Layman, B. Gelb, A. Winnick, G. Morgan, H. Tobias, L. Teperman.
A Systematic Over View of Five Year Results of Serial Protocol Kidney Transplant Biopsies.

A. Geraedts, M. Tavakol, F. Vincenti, S. Chandran, Z. Laszik, B. Lee, J. Roberts, M. Sarwal.
A Unique In Vitro Migration Model for Leukocyte Trans-Lymphatic Endothelial Migration.

Y. Xiong,¹ C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹
A Users Guide to Maximizing Utility and Outcome in >70 Year Old Donors.

K. Halazun, E. Przybyszewski, B. Samstein, E. Verna, A. Fox, R. Brown, J. Emond.
A Virtual Crossmatch Algorithm That Mimics the Sensitivity of Flow Cytometric Crossmatch.

P. Rao, D. Deo, C. Rhodes, D. King, P. Bowe, J. Napoleon, I. Okere.
A Visualization Software Platform for Managing a Kidney Paired-Donation Program.

M. Bray,¹ W. Wang,¹ M. Rees,² P. Song,¹ A. Leichtman,³ V. Ashby,¹ J. Kalbfleisch.¹
A Web-Based Survey of Academic Transplant Nephrologists in the U.S. on Relative Value Unit (RVU)-Based Productivity Assessment and Financial Compensation.

W. Chon,¹ M. Pavlakis,³ P. Witkowski,⁴ L.-X. Chen,¹ P. Kadambi.²
A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.

B. Kaplan, K. MaCague, D. Patel, F. Vincenti.
A2 Kidneys into B Recipients: Is Postoperative Anti-A1 Titer Monitoring Useful?

A. DeMers, R. Forbes, D. Moore, K. Smith, D. Shaffer.
ABO Incompatible Living Related Kidney Transplantation: Results of a Matched-Pair Analysis with ABO Compatible Living Donation.

T. Vowinkel,¹ H. Wolters,² S. Reuter,³ T. Vogel,¹ N. Senninger,¹ B. Suwelack.³
ABO-Incompatible Living Kidney Transplantation at Multicenter Japanese Case Series: Evolution of Outcomes and Immunosuppressive Management.

K. Tanabe,¹ M. Okumi,¹ M. Furusawa,¹ K. Unagami,¹ T. Hirai,¹ H. Shirakawa,² T. Shimizu,¹ K. Omoto,³ M. Inui,¹ H. Ishida.¹
Abrogating Donor-Derived Myd88 Signaling Impairs the Recruitment of Recipient Neutrophils and CD8 T Cells into Lung Allografts in Mice.

Z. Zheng,¹ J.-J. Wang,¹ X. Yeap,¹ X. Kang,¹ Y. Xie,¹ X. Luo,² Z. Zhang.¹
Absence of Acute Allograft Rejection in the Early Post Operative Period in a Full Face VCA Recipient with a Positive B-Cell Flow Cytometric Crossmatch Utilizing an Induction Immunosuppression Regimen Including Anti-thymocyte and Anti-CD20 Agents.

B. Gelb,³ M. Plana,¹ D. Dadhania,² M. Suthanthiran,² J. Diaz-Siso,¹ E. Rogriguez.¹
Absence of Host CD137 Signaling Converts Chronic GVHD Toward Acute GVHD.

H. Cho,^1,3 J. Lee,^1,4 J. Kim,¹ U. Moon,¹ B. Kwon,^1,2 S. Park,³ K. Park.⁴
Absence of Receptors for C3a or C5a Prevent Alloreactive CD8 T Effector Cell (Teff) Expansion but Differentially Impact Memory (Tmem) Persistence Posttransplantation.

D. Mathern, P. Heeger.
Accepted Mouse Kidney Allografts Are Characterized by Widespread Nitrosylation.

I. Aljabban, B. Jiang, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.
Accumulation of Highly Sensitized Patients in a KPD Registry.

S. Stepkowski, B. Mierzejewska, D. Bekbolsynow, M. Rees.
Achieving Timely Therapeutic Mycophenolic Acid Levels in Pediatric Lung Transplant Patients.

C. Kam, S. Kim, E. Melicoff.
Acquired Down-Regulation of B Cell Function Induced by Donor Blood Group Antigens After ABO-Incompatible Kidney Transplantation.

M. Tasaki,¹ K. Saito,¹ Y. Nakagawa,¹ N. Imai,² T. Aoki,³ M. Kamimura,³ K. Takahashi,¹ Y. Tomita.¹
Activated Cytoprotective Mechanisms in DBD Kidneys Correlate with Kidney Function in Transplant Recipients: A Study Using Clinical Samples from the UK QUOD Biobank.

M. Kaisar,¹ L. van Dullemen,² Z. Akhtar,¹ M. Lo Faro,¹ H. Huang,¹ H. Leuvenink,² B. Kessler,¹ R. Ploeg.¹
Activating Transcription Factor 5 (ATF5) Regulates Liver Ischemia/Reperfusion Injury.

G.-Q. Shen,² M. Morita,¹ J. Fung,² L. Lu,^1,2 S. Qian.^1,2
Activation of Alloreactive T Cells by Allogeneic Exosomes and Cells Cross-Dressed with Allogeneic MHC Molecules.

M. Babiker-Mohamed, J. Marino, P. Crosby, G. Benichou.
Activation of Innate Immunity During Human OLT-IRI Triggers Adaptive Immunity and Correlates with the Degree of IRI Injury.

A. Zarrinpar,¹ R. Sosa,² P. Rao,² C. Lassman,² R. Busuttil,¹ D. Gjertson,² J. Kupiec-Weglinski,¹ E. Reed.²
Acute Allograft Glomerulopathy: A Distinct Form of Cellular Rejection.

O. AL-Badri, M. Alexander, F. Cosio, L. Cornell.
Acute Inflammation, Chronic Damage and Renal Dysfunction in Renal Transplant Recipients with Delayed Graft Function (DGF).

A. Cherukuri, R. Mehta, P. Sood, P. Randhawa, A. Tevar, S. Hariharan.
Acute Kidney Injury (AKI) Associated with Chronic Kidney Disease (CKD) in Paediatric Non-Kidney Transplant Recipients.

C. Williams,^1,2 K. Borges,² T. Banh,² J. Vasilevska-Ristovska,² R. Chanchlani,^1,2 V. Ng,^1,2 A. Dipchand,^1,2 M. Solomon,^1,2 D. Hebert,^1,2 S. Kim,^1,3 B. Astor,⁴ R. Parekh.^1,2,3
Acute Kidney Injury After Liver Transplantation Is Set in Motion Early After Reperfusion of the Liver Graft: A Prospective Cohort Study.

I. Jochmans,¹ N. Meurisse,² D. Monbaliu,¹ J. Pirenne.¹
Acute Kidney Injury and Chronic Kidney Disease in Donation After Circulatory Death Liver Transplantation: UK Single Centre Study.

I. Umbro,^1,2 F. Tinti,^1,2 F. Evison,³ A. Sharif,⁴ B. Gunson,⁵ A. Mitterhofer,² J. Ferguson,¹ P. Muiesan.¹
Acute Operative Complications and 1,5,& 10 Year Outcomes in Living Donors by Type of Live Donor Nephrectomy – UK Cohort Study.

N. Krishnan,¹ L. Bradbury,² N. Raymond.¹
Acute Rejection by Belatacept (Bela) Dosing Frequency: Results from a Phase II Study of Kidney Transplant Recipients.

F. Vincenti,¹ G. Blancho,² A. Durrbach,³ G. Grannas,⁴ J. Grinyó,⁵ U. Meier-Kriesche,⁶ M. Polinsky,⁶ H. Zhao,⁶ C. Larsen.⁷
Acute Rejection in Non-Human Primates Treated with Belatacept Is Mediated by a Unique CD8 Memory Subset.

D. Mathews,¹ W. Wakwe,¹ M. Lowe,¹ C. Breeden,¹ F. Leopardi,¹ A. Farris,¹ M. Song,¹ E. Strobert,² J. Jenkins,² C. Larsen,¹ R. Townsend,³ A. Adams.¹
Acute Rejection Profoundly Impacts Graft Survival in Young but Not in Old Kidney Transplant Recipients.

C. Denecke,^1,3 M. Biebl,^1,3 J. Fritz,² A. Brandl,^1,4 S. Weiss,^1,4 T. Dziodzio,^1,3 F. Aigner,^1,3 R. Sucher,^1,3 C. Bösmüller,¹ J. Pratschke,^1,3,4 R. Öllinger.^1,3
Acute Rejection, New-Onset Diabetes After Transplant and Transplant Outcomes in Pediatric Kidney Recipients: Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) Database.

A. Mehrnia, T. Le, T. Tamer, S. Bunnapradist.
Acute Rejection: A Major Cause of Death-Censored Kidney Allograft Failure.

M. Alkadi,¹ J. Kim,¹ C. Hartono,² M. Aull,¹ T. Muthukumar.¹
Acute Rejections and Incidence of De Novo DSA Depend on Donor Factors and Deceased Donor Kidney Associated Risk Assessed by the Kidney Donor Profile Index (KDPI).

O. Staeck, D. Khadzhynov, L. Lehner, A. Kleinsteuber, M. Duerr, E. Schrezenmeier, K. Budde, F. Halleck.
Acute-on-Chronic Liver Failure Admissions Cost 3 Times More Than Non-ACLF Related Admissions.

S. Leffingwell, J. O'Leary, S. Asrani.
Adding an Antimetabolite to a Calcineurin-Inhibitor-Based Immunosuppression Regimen Leads to Improved Native Renal Function After Liver Transplantation.

A. Karim, D. Conway, G. Leverson, J. Mezrich, L. Fernandez, A. D'Alessandro, D. Foley.
Adding Anti-Inflammatory Agents During Normothermic Ex-Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation.

N. Goldaracena, E. Juan, K. Moritz, V. Spetzler, A. Barbas, D. Grant, M. Selzner.
Adenovirus Infection in Kidney Transplant Recipients: Report of a Case Series.

C. Simancas-Ruiz, L. Marino-Vazquez, A. Meraz-Muñoz, A. Nuñez-Abreu, R. Rivera-Marfil, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.
Adherence Patterns in Adolescent and Young Adult Kidney Transplant Recipients.

J. Boucquemont,^1,2 B. Foster,^1,2 The TAKE-IT Investigators.
Adiponectin Is Produced by Leukocytes Infiltrating Renal Transplants.

S. Goparaju, R. Fan, K. Keslar, N. Dvorina, W. Baldwin III.
Administration of IL-33 Before Allogeneic Stem Cell Transplantation Expands Recipient Treg That Prevent Graft- vs. Host Disease.

B. Matta,¹ D. Reichenbach,² X. Zhang,¹ B. Koehn,² L. Mathews,¹ C. Feser,² M. Smith,² Q. Liu,¹ R. Zeiser,³ B. Blazar,² H. Turnquist.¹
Adopting the Kidney Donor Profile Index (KDPI)/Kidney Donor Risk Index (KDRI) for Japanese Donors After Cardiac Death.

M. Kusaka,¹ A. Kawai,¹ N. Fukami,¹ H. Sasaki,¹ H. Takahashi,² T. Ito,³ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.

S.-Y. Kim,¹ S. Cho,¹ M.-J. Cho,¹ C. Lee,¹ A. Han,¹ C. Choi,¹ S. Ahn,¹ S.-I. Min,¹ S.-K. Min,¹ M. Park,² I. Jung,³ S. Kim,⁴ J. Ha.^1,2
African Americans and Organ Donation: Where Do We Go After Moving from the Bottom to the Top?

C. Callender,¹ N. Koizumi,² P. Miles,³ J. Melancon.³
African Americans Have Greater Odds of Late Stage Diagnosis of Hepatocellular Carcinoma in Mississippi.

M. Aru, S. Seals, B. Ingram, A. Seawright, C. Anderson, T. Earl.
African-American Primary Renal Transplant Recipients Are at a Significantly Higher Risk to Develop De Novo DSA.

M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,³ C. Morgan,² A. Maldonado,⁴ A. Nguyen,¹ P. Terasaki.¹
After Alemtuzumab Induction, Tac+MMF Is Superior to CsA+MMF in Pediatric Kidney Transplantation.

M. Kaabak,¹ N. Babenko,¹ A. Zokoyev,¹ R. Shapiro.²
Age Adapted Immunosuppression for Elderly Kidney Allograft Recipients: Balancing Risks for Cancer versus Rejection.

F. Jackson-Spence,¹ H. Gillott,¹ S. Tahir,¹ F. Evison,² J. Nath,³ A. Sharif.³
Age and Education Level Are Predictors of Patient Preferences for Educational Formats in ESRD Patients Undergoing Transplant Education.

K. Leick,¹ J. Jones,¹ S. Witte,² L. Hunsicker,³ Z. Stewart.¹
Age Gap Analysis Between Live Donor and Recipients in Kidney Transplantation: Opportunities to Improve Voluntary Exchange Programs and Kidney Paired Donation.

J. Rodriguez,¹ A. Patel,² M. Goggins.²
Age-Based High GFR Associates with Clinical Risk Among Potential Living Donors, but Only with Increased Nephron Number Among Approved Donors.

H. Chakkera,¹ E. Poggio,³ A. Denic,² J. Mathew,² W. Kremers,² J. Larson,² H. Amer,² F. Cosio,² M. Stegall,² S. Taler,² A. Rule.²
Ageing as a Barrier to Transplant Tolerance.

J. Kim, R. Stott, H. Deirawan, L. Kojima, L. Washburn, G. Zhao, H. Yeh, J. Markmann.
Aging Is Critically Impacting the Efficacy of Immunosuppressants.

J. Schuitenmaker, K. Edtinger, M. Seyda, H. Uehara, M. Quante, A. ElKhal, S. Tullius.
Air Pollution – An Additional Risk Factor for Developing Cardiac Allograft Vasculopathy.

C. Bara, D. Böthig, Y. Scheibner, D. Bobylev, B. Przybylek, A. Haverich.
Airway Inflammation and Symptoms in Children Following Liver and Heart Transplantation.

A. Redmann,¹ J. Bucuvalas,² R. Wood,³ C. Chin,⁴ C. Hart.¹
Alemtuzumab Induction Allows Better Rejection Free Graft Survival in Comparison to Basiliximab Although with Increased Post Transplant Viral Infections.

V. Siddagangaiah,¹ H. Sharma,² N. Lal,¹ J. Rai,¹ M. Howse,¹ D. Ridgway,¹ A. Sharma,¹ A. Hammad,¹ S. Mehra.¹
Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.

I. Yakubu,¹ B. Masters,¹ B. Ravichandran,¹ T. Sparkes,¹ M. Moss,¹ F. Rasetto,¹ S. Jonchhe,¹ B. Thomas,² N. Costa,² D. Leeser,² S. Bartlett,² A. Haririan.²
Alemtuzumab Is Safe and Effective Induction Therapy in Highly Sensitized (HS) Pediatric Patients Undergoing Transplantation.

I. Kim,¹ J. Choi,¹ A. Vo,¹ A. Kang,¹ M. Toyoda,¹ J. Mirocha,² E. Kamil,¹ S. Louie,¹ O. Galera,¹ S. Jordan,¹ D. Puliyanda.¹
Alkaline Phosphatase a New Marker for Graft Outcome and High Pulse Wave Velocity in Renal Transplant Recipients.

S. Sezer,¹ E. Tutal,¹ Z. Bal,¹ B. Demirci,¹ M. Haberal.²
Allo-Specific Memory B Cell Recall Responses Are Dependent on B Cell Autophagy.

J. Leventhal,¹ M. Fribourg,² J. Ni,¹ P. Heeger.¹
Alloantibody Suppression by Bruton Tyrosine Kinase Antagonist Ibrutinib Is Associated with a Moderate Splenic B-Cell Reduction.

N.-N. Chai, I. Kim, S. Jordan, A. Klein, G. Wu.
Allograft TLR4 Receptor Signaling Induces Specific Early Inflammatory Events in Promotes Allografts Subjected to Prolonged Cold Ischemic Storage.

T. Yagisawa, N. Kohei, D. Kish, R. Fairchild.
Alloimmunity Through Non-HLA Epitopes in Kidney Transplantation.

R. Reindl-Schwaighofer,¹ A. Kainz,¹ B. Cole,² J. van Setten,² K. Jelencsics,¹ B. Keating,² R. Oberbauer.¹
Alterations in Central Carbohydrate Metabolism in Porcine Liver Allografts Preserved with a Subnormothermic Machine Perfusion (SNMP) System.

B. Banan, A. Cyr, R. Lopez, G. Michalopoulos, P. Fontes.
Altruistic Kidney Donation: A Single US Transplant Center Experience.

A. Aguire-Alarcon,¹ M. Lubetzky,¹ M. McKinney,¹ L. Kayler.²
Altruistic Kidney Donation: From the Donor's Perspetive.

R. Burge,¹ S. Potts,^2,3 S. Lundie.⁴
Ameliorating Progression of Allograft Vasculopathy by Targeting the T Follicular Helper Cell Subset.

M. Chhabra, J. Ali, J. Alsughayyir, S. Qureshi, J. Bradley, E. Bolton, R. Motallebzadeh, G. Pettigrew.
American and European Transplant Surgeons: Research, Teaching, and Burnout.

M. Jesse,¹ M. Abouljoud,¹ A. Eshelman,¹ C. DeReyck,² J. Lerut.²
Amino Acid (AA) Metabolism During Liver Allograft Preservation Comparing Subnormothermic Machine Perfusion (MP) Against Cold Storage (CS).

B. Banan, R. Lopez, C. Hughes, G. Michalopoulos, P. Fontes.
An Analysis of Factors Associated with Pancreas Allograft Thrombosis.

J. Steggerda, K. Bornhurst, A. Annamalai, A. Peng, J. Mirocha, D. Dafoe.
An Analysis of Non-Tuberculous Mycobacteria (NTM) Infection and Colonization in Lung Transplant Recipients (LTRs) Post-Transplant: A Single Center Matched Cohort Study.

H. Kozlowski,^1,2 D. Kabbani,³ C. Chaparro,^1,2 L. Singer,^1,2 C. Rotstein,^1,2 S. Keshavjee,^1,2 S. Husain.^1,2
An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?

J. Siegel,¹ A. Humar,² P. Gianaros,¹ J. Steel.²
An Economical and Effective Vaccination Program in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Prospective Study.

W. Ju, A. Yang, Q. Ren, D. Wang, Z. Guo, Y. Ma, A. Hu, Q. Tai, X. Zhu, X. He.
An Epidemiological Update of Non-Melanoma Skin Cancer in Immunosuppressed Organ Transplant Recipients with Skin of Color.

C. Shaver, C. Cusack, C. Chung.
An Evaluation of the Safety, Efficacy, and Pharmacoeconomics of Two Valganciclovir Prophylaxis Regimens Following Renal Transplantation.

J. Chen,¹ R. Hoffman,² M. Thomas,² J. Gervasio.²
An Improved Flow Cytometry Based Platelet Counting in Xeno Perfusion Models.

S. Sendil,¹ G. Braileanu,¹ W. Sun,¹ W. Hassanein,¹ D. Parsell,¹ H. Crum,² L. Burdorf,¹ R. Pierson,¹ A. Azimzadeh.¹
An Improved Method for the Evaluation of Microvascular Inflammation in Renal Allograft Biopsies.

M. Rooney,¹ Z. Ping,² D. Samarapungavan,³ R. Hennigar.⁴
An In-Situ Treatment of Donor Skin Induces MARCH1 and Decreases MHC II Expression on Donor Dendritic Cells, Promoting Skin Allograft Acceptance.

T. Borges,^1,2 F. Machado,¹ C. Bonorino,¹ L. Riella.²
An Interventional Study Evaluating Cell Mediated Immunity to Guide Therapy for CMV Viremia.

M. Mian, A. Humar, S. Keshwani, S. Husain, P. Ashton, S. Han, L. Singer, J. Kim, E. Renner, D. Kumar.
Analysis of a Large Single-Center Cohort of Renal Transplant Recipients with Histoplasmosis.

M. Mashayekhi, A. Langone.
Analysis of Broken Chains in Kidney Paired Donation During an 8 Year Period within the National Kidney Registry.

N. Cowan,¹ J. Sinacore,² H. Gritsch,¹ J. Veale.¹
Analysis of FSGS (Focal Segmental Glomerulosclerosis) Recurrence After Renal Transplantation.

J. Mansur, G. Basso, M. Cristelli, G. Mata, T. Sandes-Freitas, G. Kirsztajn, H. Tedesco-Silva, J. Medina-Pestana.
Analysis of Intra-Graft Anti-HLA Antibodies Suggests That HLA Sensitization Occurs Long After an Allograft Nephrectomy and Is Not Due to a Release of Anti-HLA Antibodies from the Failed Kidney.

D. Milongo,¹ N. Congy-Jolivet,² A. Del Bello,¹ F. Sallusto,³ L. Esposito,¹ L. Rostaing,¹ N. Kamar.¹
Analysis of Local versus Imported Expanded Criteria Donor (ECD) Kidneys: A Single Center Experience with 497 ECD Kidney Transplants.

M. Khan,¹ H. El-Hennawy,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² M. Gautreaux,³ S. Iskandar,³ W. Doares,⁴ S. Kaczmorski,⁴ R. Stratta.¹
Analysis of T Cell Receptor Repertoire in Routine Renal Allograft Biopsy.

R. Reindl-Schwaighofer,¹ J. Weinberger,¹ R. Jimenez-Heredia,¹ J. Sunzenauer,¹ S. Schaller,² S. Winkler,² R. Oberbauer.¹
Angiotensin II Blockade and Fibroblast Growth Factor-23 in Stable Kidney Transplant Recipients.

O. Sanchez, S. Reule, S. Li, D. Berglund, R. Spong, H. Ibrahim.
Angiotensin II Type 1 Receptor Antibodies Are Associated with Allograft Loss in Pediatric Renal Transplantation.

M. Pearl,¹ Q. Zhang,² M. Palma Diaz,³ J. Grotts,⁴ J. Brook,⁴ D. Gjertson,² P. Weng,¹ E. Reed,² E. Tsai.¹
Angiotensin II Type-1 Receptor Antibodies in Renal Transplant Recipients Associated with Ventricular and Endothelial Dysfunction: Preliminary Results.

L. Figuerola-Chaparro,¹ F. Davila-Radilla,¹ E. Cuevas,² L. Castillo-Martínez,¹ A. Orea-Tejeda,¹ J. Arreola-Guerra,² J. Alberu.²
Anterior Rectus Sheath Approach for Renal Transplant: An Open Minimal Incision with Decreased Wound Complications.

S. Phillips,¹ S. Hill,¹ L. Lipscomb,¹ B. Sankari,² S.-C. Chueh,² J. Africa.²
Anti-Angiotensin II Type 1 Receptor Antibody Reduction with Proteasome Inhibitor-Based Desensitization.

A. Girnita, E. Portwood, P. Brailey, S. Tremblay, R. Alloway, E. Woodle.
Anti-BTLA Antibody (6B2) Induced Prolongation of Fully MHC-Mismatched Murine Cardiac Allograft and Generation of Foxp3+ Regulatory T Cells.

M. Uchiyama,^1,2 E. Yin,^2,3 X. Jin,^2,4 T. Shimokawa,¹ H. Yagita,⁵ M. Niimi.²
Anti-HLA Antibodies in Allogeneic and Autologous Hematopoietic Stem Cell Transplantation.

A. Bertocchi, L. Requiao-Moura, M. Torres, E. Tonato, M. Durao Junior, A. de Matos, N. Hamershclak, A. Pacheco-Silva.
Anti-HLA Antibody Composition and Outcomes in Pediatric Heart Transplant Recipients with a Positive Cross-Match.

P. Jindra,¹ S. Nicholas,² J. Chappelle,¹ T. Humlicek,² K. Hosek,² J. Heinle,² S. Denfield,² A. Jeewa,² R. Kerman,¹ W. Dreyer.²
Anti-IL6R Therapy (Tocilizumab) Improves Long-Term Patient & Graft Survival in Patients with Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.

J. Choi, A. Vo, M. Haas, D. Puliyanda, S. Louie, A. Peng, J. Kahwaji, R. Villicana, I. Kim, J. Mirocha, S. Jordan.
Anti-Inflammatory Effects of AAV-Mediated TIMP-1 Gene Transfer in Hepatic Ischemia-Reperfusion Injury.

S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.
Anti-LG3 Antibodies Enhance Renal Microvascular Rarefaction, Fibrosis and Dysfunction Associated with Ischemia-Reperfusion Injury.

B. Yang,^1,3 K. Hamelin,^1,3 M. HÉnault-Rondeau,^1,3 N. Patey,^1,2,3 J. Turgeon,^1,3 S. Lan,^1,3 L. Pomerleau,¹ J. Peng,¹ J. Tremblay,¹ M. DieudÉ,^1,3 M.-J. HÉbert,^1,3 H. Cardinal.^1,3
Anti-Thymocyte Globulin Induced Thrombocytopenia and Bleeding After Kidney Transplantation.

M. Dokus,¹ A. Patel,¹ J. Iuppa,² E. Venniro,³ A. Danzig,¹ J. Cooley,² J. Taylor,³ R. Kashyap,¹ M. Orloff.¹
Anti-Thymocyte Globulin Induction Does Not Increase the Risk of Thrombotic Events in Kidney Transplantation: A Matched Case-Control Study.

J. Iuppa,¹ M. Dokus,² E. Venniro,³ A. Patel,² A. Danzig,⁴ J. Hahn,¹ R. Kashyap,² M. Orloff,² J. Taylor.³
Antibody Mediated Rejection and Mixed Acute Rejection: Long Term Results and Predictive Factors for Graft Loss Following Proteasome Inhibitor Therapy.

A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ B. Abu-Jawdeh,¹ A. Govil,¹ G. Mogilishetty,¹ M. Cardi,² J. Kremer,² M. Cuffy,^1,2 F. Paterno,¹ A. Shields,^1,2 D. Witte,¹ R. Alloway,¹ E. Woodle.¹
Antibody Titers as Predictors of Kidney Graft Outcomes.

A. Gilbert,¹ M. Zaheer,¹ O. Timofeeva,² S. Rosen-Bronson,² M. Awwad,² D. Li,² M. Grafals,¹ B. Javaid,¹ P. Abrams,¹ J. Verbesey,¹ M. Cooper.¹
Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative.

J. Reeve,¹ P. Halloran.²
Antibody-Mediated Rejection in Pancreas Transplantation.

O. Serrano,¹ D. Vock,² E. Finger,¹ R. Kandaswamy,¹ D. Sutherland,¹ T. Dunn.¹
Antithymocyte (ATG) Dose Density in Renal Transplant Recipients (RTR) with Early Graft Dysfunction (EGD).

S. Kuten, S. Patel, R. Knight, D. Nguyen, E. Graviss, H. Podder, A. Gaber.
Antithymocyte Globulin (ATG) versus Anti-interleukin-2 Receptor (Anti-IL-2R) as Induction Therapy for Kidney Transplantation After a Nonrenal Transplant.

H. Mai,¹ K. Trébern-Launay,¹ C. Legendre,² M. Kessler,³ L. Rostaing,⁴ V. Garrigue,⁵ E. Morelon,⁶ S. Brouard,¹ M. Giral,¹ J.-P. Soulillou.¹
aPC Pretreatment of hEPCR-Expressing PAECs Attenuates Endothelial Cell Damage and Thrombosis.

C. Laird,¹ B. French,¹ D. Harris,¹ X. Chang,¹ D. Ayares,² R. Pierson,¹ A. Azimzadeh.¹
Appraisal of Alternative Immunosuppression Regimens in Intestinal Transplant Recipients: A Single Center Experience.

R. Patel, M. Keck, D. Collier, M. Vacha.
Aquaporin 4 Blockade Is a Novel Strategy to Prevent T Cell Activation and Effector Functions.

K. Ayasoufi,¹ N. Kohei,¹ G. Farr,² P. McGuirk,² M. Pelletier,² R. Fairchild,¹ A. Valujskikh.¹
Are Prior Living Kidney Donors with ESRD Being Listed and Receiving Transplantation Priority in a Timely Manner?

J. Wainright, A. Kucheryavaya, D. Klassen, D. Stewart.
Are Random Tacrolimus Levels in the Emergency Department Costing You Money?

B. Lee, D. Jain, M. Campara.
Are We Refusing Good Organs? Outcomes of Ventilator Management of Sub-Optimal Lung Donors.

B. Scully,¹ D. Horne,¹ J. Heinle,¹ E. McKenzie,¹ K. Hosek,² W. Zhang,² G. Mallory,³ E. Melicoff.³
Arterial Hypertension After Renal Transplantation in Pediatric Patients: An Analysis of CERTAIN Registry.

R. Sugianto,¹ E. Wühl,² B. Schmidt,¹ K. Krupka,² B. Höcker,² B. Tönshoff,² A. Melk.¹
Arteriolar Hyalinosis on Renal Transplant Protocol Biopsies Is Not Associated with Tacrolimus Exposure.

S. Yilmaz,¹ D. Shaffer,² Y. Qazi,³ F. Shihab,⁴ K. McCague,⁵ D. Patel,⁵ F. Vincenti.⁶
Aryl Hydrocarbon Receptor Expression Increases in Skin Graft-infiltrating Th1 and Treg Cells.

J. Fechner, W. Julliard, L. Owens, J. Mezrich.
ASC-Deficient Dendritic Cells Exhibit Activation Defects and a Reduced Ability to Stimulate Allogeneic T Cells.

A. Scheinok, A. Shigeoka, S. Kasimsetty, R. Elahimehr, D. McKay.
Assessing Return of CMV Specific Cellular Immunity Using the T-SPOT.CMV Soon After Kidney Transplant with Thymoglobulin.

C. Kotton.
Assessing the Impact of the Share35 Liver Allocation Policy: Survival Outcomes Among Liver Re-Transplant Recipients.

J. Ortiz,¹ N. Koizumi,² C. Kwon,² Y. Zhang,² C. Ortiz.³
Assessing the Induction of Tolerance to Vascularized Composite Allotransplantation in Miniature Swine.

J. Walch, J. Alonso-Escalante, H. Wang, B. Oh, M. Iglesias, A. Lee, G. Brandacher, G. Raimondi.
Assessing the Role of Everolimus in Reducing Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation for Patients within UCSF Criteria: Re-Inventing the Role of Mammalian Target of Rapamycine Inhibitors.

L.-B. Jeng, A. Thorat, H.-R. Yang, T.-H. Chen, S.-C. Hsu.
Assessing Vaccination Status in Transplant Candidates and Recipients: Current Status and Challenges to Successful Implementation.

H. Leung, K. Cameron, B. Ho, M. Ison.
Assessment of Chikungunya IgM Prevalence Among Deceased Organ and Tissue Donors Using Two Enzyme Immunoassay (EIA) Kits.

H. Prince, M. Altrich, M. Nowicki.
Assessment of Molecular Mechanisms of Non-Transplant Cardiac Hypertrophy in Cardiac Allograft Hypertrophy – An Exploratory Gene Array Study of Myocardial Biopsy Samples.

R. Araujo-Gutiérrez,^1,2 S. Ibarra-Cortez,^1,2 M. Park,¹ J. Estep,¹ G. Ashrith,¹ B. Trachtenberg,¹ G. Torre-Amione,¹ K. Youker,^1,2 A. Bhimaraj.¹
Assessment of mRNA Gene Profiles in Plasma Exosome to Predict Risk for Antibody-Mediated Rejection (ABMR) of Renal Allografts.

H. Zhang,¹ J. Kahwaji,¹ P. Li,² S. Ge,¹ D. Thomas,¹ C. Nast,³ A. Vo,¹ M. Haas,³ S. Jordan,¹ M. Toyoda.¹
Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.

J. Glick Frasiolas, J. Matthew, D. Tsapepas.
Assessment of Transplant Health Literacy of Liver Transplant Candidates and Their Caregivers.

Y. Bababekov,¹ Z. Fong,^1,2 J. Adler,¹ H. Yeh,¹ D. Chang,^1,2 J. Pomposelli.³
Association Between Delayed Graft Function and Long-Term Outcomes After Kidney Transplantation from Donors After Circulatory Death.

P. Clayton,^1,2,3 G. Russ,^1,2,3 S. McDonald,^1,2,3 S. Chadban.^1,4,5
Association Between GFR Decline and Long Term Outcome in Renal Transplantation.

A. Delay,¹ O. Moranne,² N. Maillard,¹ E. Alamartine,¹ C. Mariat.¹
Association Between Pretransplant Body Mass Index and Outcomes in Patients Undergoing Living Kidney Transplantation: A Consideration of Gender Differences.

M. Okumi,¹ K. Unagami,¹ M. Furusawa,¹ T. Hirai,¹ Y. Okabe,² K. Masutani,³ T. Shimizu,¹ K. Omoto,⁴ H. Ishida,¹ T. Kitazono,³ K. Tanabe,¹ The Japan Academic Consortium of Kidney Transplantation (JACK).
Association of Cytomegalovirus-Specific T Cell-Mediated Immunity with the Risk of CMV Infection Occurrence in Kidney Transplant Recipients.

D. Dęborska-Materkowska,¹ A. Perkowska-Ptasińska,¹ A. Sadowska,¹ D. Sitarek,¹ J. Gozdowska,¹ M. Ciszek,² M. Serwańska-Świętek,³ A. Jóźwik,³ P. Domagała,³ A. Kwiatkowski,³ M. Durlik.¹
Association of Genetic Polymorphisms in Complement Independent Pathways with Donor Specific Antibodies in Kidney Allograft Recipients.

Y. Chang,^1,2 T. Shah,^1,3 D. Min.¹
Association of Genetic Polymorphisms of Angiopoietin-Like 4 with Proteinuria in Kidney Allograft Recipients.

Y. Chang,^1,4 T. Shah,^2,4 Y.-T. Chuang,³ D. Min.⁴
Association of Neighborhood Poverty and Living Donor Kidney Transplant Rates by Donor Relationship to Recipient.

G. Vranic, A. Nishio Lucar, D. Keith.
Association of Pre-Transplant Midodrine Use and Complications After Kidney Transplantation.

T. Alhamad,¹ D. Brennan,¹ Z. Brifkani,¹ H. Xiao,² M. Schnitzler,² V. Dharnidharka,¹ D. Axelrod,³ D. Segev,⁴ K. Lentine.²
Association of Smoking Habits with Comorbidity 15 Years After Liver Transplantation.

S. Pischke,³ M. Lege,¹ L. Fischer,² U. Herden,² A. Lohse,³ B. Nashan,² M. Sterneck.¹
Association of Ultrastructural Changes in Renal Allograft Biopsies with Antibody-Mediated Rejection (AMR) and Graft Outcomes.

A. Haririan,¹ M. Chaudhry,² J. Papadimitriou,² N. Costa,¹ B. Thomas,¹ M. Mavanur,¹ R. Ugarte,¹ C. Cangro,¹ C. Drachenberg.²
Associations Between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.

S. Mansour,¹ J. Puthumana,¹ P. Reese,² I. Hall,¹ M. Doshi,³ F. Weng,⁴ B. Schröppel,⁵ H. Thiessen-Philbrook,^1,6 M. Bimali,¹ C. Parikh.¹
Associations of Perfusate Biomarkers and Pump Parameters with Delayed Graft Function and Deceased-Donor Kidney Allograft Function.

C. Parikh,¹ I. Hall,¹ R. Bhangoo,² J. Ficek,¹ P. Abt,³ H. Thiessen-Philbrook,¹ H. Lin,¹ M. Bimali,¹ P. Murray,⁴ V. Rao,¹ B. Schröppel,⁵ M. Doshi,⁶ F. Weng,⁷ P. Reese.³
Associations of Risk Factors and Kidney Retransplant Outcomes Vary Between Three Common Induction Agents: Results from the Analysis of Over Ten-Thousand Cases in Ten Years.

A. Santos, X. Wen, M. Casey, S. Rehman, K. Womer.
AT1R Antibodies at 1-Year Negatively Impact 5-Year Native Renal Function in Liver Transplant Recipients.

J. O'Leary,¹ A. Philippe,² H. Heidecke,² R. Freeman,¹ L. Jennings,¹ R. Catar,² G. Klintmalm,¹ D. Dragun.²
Attenuation of Warm Hepatic Ischemia-Reperfusion Injury by Bruton's Tyrosine Kinase Inhibition.

A. Zarrinpar,¹ T. Palumbo,¹ K. Nakamura,¹ C. Lassman,² R. Busuttil,¹ J. Kupiec-Weglinski.¹
Attitudes Toward Living Kidney Transplantation Among Potential Transplant Candidates.

K. Yu,¹ S. Kulkarni,¹ J. Gannon,¹ P. Reese,² E. Gordon,³ C. Thiessen.¹
Autologous BK-Specific T-Cell Lines in Kidney Transplant Recipients.

C. Lamarche,^1,2,3 O. Julie,^1,3 C. Carli,^1,3 J.-S. Delisle.^1,2,3
Automated Web-Based Monitoring Identifies Significant Clinical Changes in Patients Awaiting Kidney Transplant.

H. Braun, M. Parente, R. Hirose, G. Roll.
Avoidance of CNI and Steroids Using Belatacept – A Preliminary Report of CTOT-16.

R. Mannon,¹ P. Stock,² A. Mehta,³ D. Ikle,⁴ N. Watson,⁵ N. Bridges,⁵ M. Robien,⁵ K. Newell.³